Integer Holdings rises on Q4 profit beat

Shares of medical device contract development firm Integer Holdings ITGR.N rise 8.36% to $93.61

Co reports Q4 adjusted EPS of $1.76 vs analysts' average estimate of $1.70 - data compiled by LSEG

Posts Q4 sales of $472 million vs estimates of $462.7 million

Co expects 200 basis points above-market organic sales growth in 2027, CEO Payman Khales says

ITGR intends to commence accelerated share repurchase program to repurchase about $50 million of common stock

Cardio and vascular segment sales increased 11% to $284 million in Q4, driven by acquisitions and strong demand in neurovascular

Including session's moves, stock up 20.02%